NEWS RELEASE for September 17, 2003 at 7:35 AM EDT

Contact:            Allen & Caron                                                                            CLOSURE Medical Corp        

Joe Allen (investors)                        Len Hall (media)                                Benny Ward, CFO

212-691-8087                                    949-474-4300                                    919-876-7800

                        joe@allencaron.com                 len@allencaron.com    

                       

 

CLOSURE MEDICAL CORPORATION TO PRESENT AT THE UBS WARBURG

GLOBAL LIFE SCIENCES CONFERENCE

 

RALEIGH, NC (September 17, 2003) … CLOSURE Medical Corporation (Nasdaq: CLSR), a global leader in medical adhesives, is scheduled to present at the UBS Warburg Global Life Sciences Conference at The Plaza Hotel in New York City. Daniel A. Pelak, President and Chief Executive Officer, will deliver the Company's presentation on Wednesday, September 24, 2003, beginning at 12:00 p.m. EDT. A live webcast of the presentation will be available at www.closuremed.com or www.ibb.ubs.com.

 

About CLOSURE Medical Corporation

CLOSURE Medical Corporation is a global leader in the development, manufacture, and commercialization of medical adhesives based on its proprietary medical grade cyanoacrylate technology.  CLOSURE’s proprietary technology has customized the physical and chemical properties of cyanoacrylates to develop medical adhesive formulations to close and seal topical skin wounds and incisions. 

 

For additional information on CLOSURE Medical visit its website at www.closuremed.com or visit the “Clients” section of the Allen & Caron website at www.allencaron.com.